1981
DOI: 10.1002/art.1780241210
|View full text |Cite
|
Sign up to set email alerts
|

Evidence of a Generalized Metabolic Defect in Patients with Hereditary Chondrocalcinosis

Abstract: A gene in the heterozygous state appears responsible for a 2‐fold increase in pyrophosphate content of both fibroblasts and lymphoblasts cultured from patients who have dominantly inherited chondrocalcinosis. Cells from unaffected family members of this large kindred showed a pyrophosphate content in the same range as was found in unaffected, unrelated controls. Similar cells from individuals homozygous for the gene would be useful in delineating the precise biochemical abnormality responsible for the increase… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
7
0

Year Published

1983
1983
2016
2016

Publication Types

Select...
8

Relationship

1
7

Authors

Journals

citations
Cited by 51 publications
(7 citation statements)
references
References 24 publications
0
7
0
Order By: Relevance
“…Lymphocytes and skin fibroblasts from patients with familial CPPD disease show high levels of inorganic pyrophosphate, 42 which suggests a systemic disorder. Recently, Abhishek et al found that patients with nonfamilial chondrocalcinosis had lower cortical bone mineral density and higher rates of vascular and soft-tissue calcification than those without chondrocalcinosis.…”
Section: Pisk Factors and Associated Conditionsmentioning
confidence: 99%
“…Lymphocytes and skin fibroblasts from patients with familial CPPD disease show high levels of inorganic pyrophosphate, 42 which suggests a systemic disorder. Recently, Abhishek et al found that patients with nonfamilial chondrocalcinosis had lower cortical bone mineral density and higher rates of vascular and soft-tissue calcification than those without chondrocalcinosis.…”
Section: Pisk Factors and Associated Conditionsmentioning
confidence: 99%
“…The possibility of increased pyrophosphate synthesis as the leading mechanism of CPDD crystal deposition is supported by studies from the Milwaukee group [51]. In several in vitro preparations, as well as in studies in patients with sporadic CPPDD and osteoarthritis, evidence has been reported of an increased activity of chondrocyte nucleoside triphosphate pyrophosphohydrolase (NTP-PPH) [51].…”
Section: Familial Calcium Pyrophosphate Deposition Diseasementioning
confidence: 97%
“…Cervical and lumbar laminectomy have been done in those with spinal stenosis due to calcium pyrophosphate deposition [67,70,71]. Probenecid decreases pyrophosphate synthesis [51,76], whereas phosphocitrate inhibits both the synthesis and mitogenic effects of pyrophosphate [50,83,84]. These may prove useful in the future; however, clinical studies are still not available.…”
Section: Atypical Presentationsmentioning
confidence: 99%
See 1 more Smart Citation
“…The activity of this enzyme was elevated in sporadic cases of CPPDD; however, elevated levels of NTPPPH activity were not observed in the familial form of the disease (Ryan et al 1986). Nonetheless, increased levels of inorganic pyrophosphate have been observed in cultured fibroblasts and lymphoblasts of patients affected with familial CPPDD (Lust et al 1981a(Lust et al , 1981b, which thus perpetuates the suspicion that abnormalities in pyrophosphate metabolism may give rise to abnormal crystal deposition in these families.…”
Section: Introductionmentioning
confidence: 99%